Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

HIV TAT peptide modifies the distribution of DNA nanolipoparticles following convection-enhanced delivery.

MacKay JA, Li W, Huang Z, Dy EE, Huynh G, Tihan T, Collins R, Deen DF, Szoka FC Jr.

Mol Ther. 2008 May;16(5):893-900. doi: 10.1038/mt.2008.36. Epub 2008 Mar 11.

2.

New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.

Hashizume R, Ozawa T, Gryaznov SM, Bollen AW, Lamborn KR, Frey WH 2nd, Deen DF.

Neuro Oncol. 2008 Apr;10(2):112-20. doi: 10.1215/15228517-2007-052. Epub 2008 Feb 20.

3.

Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro.

Chen JK, Hu LJ, Wang D, Lamborn KR, Deen DF.

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1538-47.

PMID:
17394949
4.

Synthesis and comparative toxicology of a series of polyhedral borane anion-substituted tetraphenyl porphyrins.

Koo MS, Ozawa T, Santos RA, Lamborn KR, Bollen AW, Deen DF, Kahl SB.

J Med Chem. 2007 Feb 22;50(4):820-7. Epub 2007 Jan 25.

PMID:
17253677
5.

Retro-convection enhanced delivery to increase blood to brain transfer of macromolecules.

Huynh GH, Ozawa T, Deen DF, Tihan T, Szoka FC Jr.

Brain Res. 2007 Jan 12;1128(1):181-90. Epub 2006 Nov 22.

PMID:
17125752
6.

Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures.

Ozawa T, Faddegon BA, Hu LJ, Bollen AW, Lamborn KR, Deen DF.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):263-70.

PMID:
16904526
7.

A genetic strategy to overcome the senescence of primary meningioma cell cultures.

Baia GS, Slocum AL, Hyer JD, Misra A, Sehati N, VandenBerg SR, Feuerstein BG, Deen DF, McDermott MW, Lal A.

J Neurooncol. 2006 Jun;78(2):113-21. Epub 2006 Mar 23.

PMID:
16554968
8.

Barriers to carrier mediated drug and gene delivery to brain tumors.

Huynh GH, Deen DF, Szoka FC Jr.

J Control Release. 2006 Jan 10;110(2):236-259. doi: 10.1016/j.jconrel.2005.09.053. Epub 2005 Nov 28. Review.

PMID:
16318895
9.

Orthotopic growth of human glioma cells quantitatively and qualitatively influences radiation-induced changes in gene expression.

Camphausen K, Purow B, Sproull M, Scott T, Ozawa T, Deen DF, Tofilon PJ.

Cancer Res. 2005 Nov 15;65(22):10389-93.

10.

Bromophenol blue staining of tumors in a rat glioma model.

Ozawa T, Britz GW, Kinder DH, Spence AM, VandenBerg S, Lamborn KR, Deen DF, Berger MS.

Neurosurgery. 2005 Nov;57(5):1041-7; discussion 1041-7.

PMID:
16284574
11.

Chromosome transfer experiments link regions on chromosome 7 to radiation resistance in human glioblastoma multiforme.

Misra A, Pellarin M, Hu L, Kunwar S, Perhouse M, Lamborn KR, Deen DF, Feuerstein BG.

Genes Chromosomes Cancer. 2006 Jan;45(1):20-30.

PMID:
16130123
12.

Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.

Ozawa T, Afzal J, Lamborn KR, Bollen AW, Bauer WF, Koo MS, Kahl SB, Deen DF.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):247-52.

PMID:
16111595
13.

In vivo evaluation of the boronated porphyrin TABP-1 in U-87 MG intracerebral human glioblastoma xenografts.

Ozawa T, Santos RA, Lamborn KR, Bauer WF, Koo MS, Kahl SB, Deen DF.

Mol Pharm. 2004 Sep-Oct;1(5):368-74.

PMID:
16026007
14.

Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions.

Camphausen K, Purow B, Sproull M, Scott T, Ozawa T, Deen DF, Tofilon PJ.

Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8287-92. Epub 2005 May 31.

15.

Hypoxia-induced BAX overexpression and radiation killing of hypoxic glioblastoma cells.

Chen JK, Hu LJ, Wang J, Lamborn KR, Kong EL, Deen DF.

Radiat Res. 2005 Jun;163(6):644-53.

PMID:
15913396
16.

Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitro.

Arvold ND, Guha N, Wang D, Matli M, Deen DF, Warren RS, Haas-Kogan DA.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):207-12.

PMID:
15850923
17.
18.

Functionality of hypoxia-induced BAX expression in a human glioblastoma xenograft model.

Ozawa T, Hu JL, Hu LJ, Kong EL, Bollen AW, Lamborn KR, Deen DF.

Cancer Gene Ther. 2005 May;12(5):449-55.

PMID:
15706354
19.

Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy.

Wang D, Ruan H, Hu L, Lamborn KR, Kong EL, Rehemtulla A, Deen DF.

Cancer Gene Ther. 2005 Mar;12(3):276-83.

PMID:
15650767
20.

Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.

Ozawa T, Gryaznov SM, Hu LJ, Pongracz K, Santos RA, Bollen AW, Lamborn KR, Deen DF.

Neuro Oncol. 2004 Jul;6(3):218-26.

21.

Detection of hypoxia in human brain tumor xenografts using a modified comet assay.

Wang J, Klem J, Wyrick JB, Ozawa T, Cunningham E, Golinveaux J, Allen MJ, Lamborn KR, Deen DF.

Neoplasia. 2003 Jul-Aug;5(4):288-96. doi: 10.1016/S1476-5586(03)80022-2.

22.
23.

Growth of human glioblastomas as xenografts in the brains of athymic rats.

Ozawa T, Wang J, Hu LJ, Bollen AW, Lamborn KR, Deen DF.

In Vivo. 2002 Jan-Feb;16(1):55-60.

PMID:
11980362
24.

Use of hypoxia-regulated gene expression in tumor-specific gene therapy.

Ruan H, Deen DF.

Curr Opin Investig Drugs. 2001 Jun;2(6):839-43. Review.

PMID:
11572667
25.

Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma.

Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO.

Cancer Res. 2001 Sep 15;61(18):6674-8.

26.

A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy.

Ruan H, Su H, Hu L, Lamborn KR, Kan YW, Deen DF.

Neoplasia. 2001 May-Jun;3(3):255-63.

27.

Radiation-induced DNA double-strand breaks and rejoining in malignant glioma cells.

Ozawa T, Wang J, Lamborn KR, Deen DF.

Int J Radiat Biol. 1999 May;75(5):563-70.

PMID:
10374938
28.

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption.

Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF, Shuman MA.

Neoplasia. 2000 Jul-Aug;2(4):306-14.

29.

Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX.

Ruan H, Wang J, Hu L, Lin CS, Lamborn KR, Deen DF.

Neoplasia. 1999 Nov;1(5):431-7.

30.

Induction and characterization of human glioma clones with different radiosensitivities.

Wang J, Hu L, Gupta N, Shamseldin T, Ozawa T, Klem J, Cardell M, Deen DF.

Neoplasia. 1999 Jun;1(2):138-44.

31.

Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein.

Maletínská L, Blakely EA, Bjornstad KA, Deen DF, Knoff LJ, Forte TM.

Cancer Res. 2000 Apr 15;60(8):2300-3.

32.

Boronated protoporphyrin (BOPP): localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels.

Callahan DE, Forte TM, Afzal SM, Deen DF, Kahl SB, Bjornstad KA, Bauer WF, Blakely EA.

Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):761-71.

PMID:
10524433
33.

Radiopotentiation of human brain tumor cells by sodium phenylacetate.

Ozawa T, Lu RM, Hu LJ, Lamborn KR, Prados MD, Deen DF.

Cancer Lett. 1999 Aug 3;142(2):139-46.

PMID:
10463769
34.

p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors.

Haas-Kogan DA, Kogan SS, Yount G, Hsu J, Haas M, Deen DF, Israel MA.

Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):399-403.

PMID:
10030268
35.

Characterization of human glioblastoma xenograft growth in athymic mice.

Ozawa T, Wang J, Hu LJ, Lamborn KR, Bollen AW, Deen DF.

In Vivo. 1998 Jul-Aug;12(4):369-74.

PMID:
9706486
36.

Effects of DFMO on glioma cell proliferation, migration and invasion in vitro.

Terzis AJ, Pedersen PH, Feuerstein BG, Arnold H, Bjerkvig R, Deen DF.

J Neurooncol. 1998 Jan;36(2):113-21.

PMID:
9525811
37.

Radiation-induced damage in two human glioma cell lines as measured by the nucleoid assay.

Wang J, Hu L, Allalunis-Turner MJ, Day RS 3rd, Deen DF.

Anticancer Res. 1997 Nov-Dec;17(6D):4615-8.

PMID:
9494578
38.

Effects of Matrigel on the SF-767 malignant glioma athymic mouse tumor model.

Wyrick BJ, Ozawa T, Lamborn KR, Bollen AW, Deen DF.

Anticancer Res. 1997 Jul-Aug;17(4A):2419-25.

PMID:
9252657
39.

Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation.

Gupta N, Hu LJ, Deen DF.

Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):885-95.

PMID:
9128966
40.

p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma.

Haas-Kogan DA, Yount G, Haas M, Levi D, Kogan SS, Hu L, Vidair C, Deen DF, Dewey WC, Israel MA.

Int J Radiat Oncol Biol Phys. 1996 Aug 1;36(1):95-103.

PMID:
8823264
41.

A statistical approach for analyzing clonogenic survival data.

Gupta N, Lamborn K, Deen DF.

Radiat Res. 1996 May;145(5):636-40.

PMID:
8619031
42.

P53-independent apoptosis: a mechanism of radiation-induced cell death of glioblastoma cells.

Haas-Kogan DA, Dazin P, Hu L, Deen DF, Israel A.

Cancer J Sci Am. 1996 Mar-Apr;2(2):114-21.

PMID:
9166509
43.

Cytogenetic damage and the radiation-induced G1-phase checkpoint.

Gupta N, Vij R, Haas-Kogan DA, Israel MA, Deen DF, Morgan WF.

Radiat Res. 1996 Mar;145(3):289-98.

PMID:
8927696
44.

Measurement of radiation-induced damage in human glioma cells with flow cytometry.

Wang J, Hyun W, Lamborn K, Deen DF.

Cancer Res. 1996 Jan 1;56(1):154-7.

45.

Comments on the use of paclitaxel as a radiation sensitizer.

Gupta N, Deen DF.

Int J Radiat Oncol Biol Phys. 1995 Aug 30;33(1):239. No abstract available.

PMID:
7642427
47.

Radiation-induced changes in nucleoid halo diameters of aerobic and hypoxic SF-126 human brain tumor cells.

Wang J, Basu HS, Hu L, Feuerstein BG, Nederlof PM, Deen DF.

Cytometry. 1995 Feb 1;19(2):107-11.

48.

Two polyamine analogs (BE-4-4-4 and BE-4-4-4-4) directly affect growth, survival, and cell cycle progression in two human brain tumor cell lines.

Bergeron CJ, Basu HS, Marton LJ, Deen DF, Pellarin M, Feuerstein BG.

Cancer Chemother Pharmacol. 1995;36(5):411-7.

PMID:
7634383
49.

Design and testing of novel cytotoxic polyamine analogues.

Basu HS, Marton LJ, Pellarin M, Deen DF, McManis JS, Liu CZ, Bergeron RJ, Feuerstein BG.

Cancer Res. 1994 Dec 1;54(23):6210-4.

50.

Pretreatment with the polyamine analog 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4) inhibits etoposide cytotoxicity in U-251 MG (NCI) human brain tumor cells.

Smirnov IV, Feuerstein BG, Pellarin M, Marton LJ, Deen DF, Basu HS.

Cell Mol Biol (Noisy-le-grand). 1994 Nov;40(7):975-80.

PMID:
7849564

Supplemental Content

Support Center